NEU 3.32% $20.52 neuren pharmaceuticals limited

I think the issue with the stock now is that material news which...

  1. 264 Posts.
    lightbulb Created with Sketch. 12
    I think the issue with the stock now is that material news which is Phase 3 trofinetide results in 2HCY21 are more than 12 months away. In between the IND approval and start of Phase 2 NNZ-2591 will be positive but unlikely to be a huge stock mover.. A bit more longer horizon and patience required with this one now..
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$20.52
Change
0.660(3.32%)
Mkt cap ! $2.622B
Open High Low Value Volume
$20.00 $20.66 $19.94 $6.431M 315.4K

Buyers (Bids)

No. Vol. Price($)
1 1024 $20.52
 

Sellers (Offers)

Price($) Vol. No.
$20.53 285 1
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.